biote Corp. SEC filings BTMD

biote Corp. has 411 filings in SEC EDGAR's recent list, going back to Aug 6, 2020. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

biote Corp. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
8-K/A Amended current report
Officer or director change
Jun 17, 2026 Jun 12, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 2, 2026 May 27, 2026
8-K Current report
Shareholder vote results
May 18, 2026 May 12, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
8-K Current report
Regulation FD disclosure
Apr 3, 2026 Apr 3, 2026
8-K Current report
Results of operations
Mar 11, 2026 Mar 11, 2026
8-K Current report
Other events
Jan 26, 2026 Jan 26, 2026
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 9, 2025 Jun 5, 2025
8-K Current report
Officer or director change
Jun 5, 2025 Jun 2, 2025
8-K Current report
Shareholder vote results
May 14, 2025 May 13, 2025
8-K Current report
Results of operations, Exit or restructuring costs
May 7, 2025 May 1, 2025
8-K Current report
Officer or director change
Apr 24, 2025 Apr 22, 2025
8-K Current report
Regulation FD disclosure
Mar 17, 2025 Mar 17, 2025
8-K Current report
Results of operations
Mar 12, 2025 Mar 12, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 30, 2025 Jan 29, 2025
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Material agreement
Jul 5, 2024 Jun 28, 2024
8-K Current report
Officer or director change
Jul 3, 2024 Jul 2, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Jun 21, 2024 Jun 14, 2024
8-K Current report
Shareholder vote results
May 24, 2024 May 21, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Apr 29, 2024 Apr 23, 2024
8-K Current report
Regulation FD disclosure
Mar 14, 2024 Mar 14, 2024
8-K Current report
Results of operations
Mar 12, 2024 Mar 12, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Feb 20, 2024 Feb 13, 2024
8-K Current report
Other events
Jan 25, 2024 Jan 25, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 17, 2024 Jan 17, 2024
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 11, 2024 Jan 8, 2024
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Material agreement, Change to shareholder rights, Shareholder vote results, Other events
Jun 9, 2023 Jun 8, 2023
8-K Current report
Other events
Jun 7, 2023 Jun 5, 2023
8-K Current report
Shareholder vote results
May 19, 2023 May 17, 2023
8-K Current report
Results of operations, Other events
May 9, 2023 May 9, 2023
8-K Current report
Results of operations
Mar 28, 2023 Mar 28, 2023
8-K Current report
Restatement
Mar 24, 2023 Mar 24, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change
Feb 22, 2023 Feb 15, 2023
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 7, 2022 Nov 3, 2022
8-K Current report
Regulation FD disclosure
Oct 11, 2022 Oct 10, 2022
8-K Current report
Regulation FD disclosure
Aug 25, 2022 Aug 25, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 24, 2022 Aug 24, 2022
8-K/A Amended current report
Results of operations
Aug 15, 2022 Aug 9, 2022
8-K Current report
Results of operations
Aug 10, 2022 Jul 20, 2022
8-K Current report
Material agreement, Unregistered share sale
Jul 28, 2022 Jul 27, 2022
8-K Current report
Material agreement
Jul 19, 2022 Jul 19, 2022
8-K Current report
Listing notice
Jul 19, 2022 Jul 18, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Jun 9, 2022 Jun 8, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change
Jun 2, 2022 May 26, 2022
8-K Current report
Listing notice, Regulation FD disclosure
May 27, 2022 May 26, 2022
8-K Current report
Shareholder vote results, Regulation FD disclosure
May 25, 2022 May 24, 2022
8-K Current report
Regulation FD disclosure
May 11, 2022 May 11, 2022
8-K/A Amended current report
Other events
May 4, 2022 Mar 4, 2021
8-K Current report
Regulation FD disclosure
Mar 30, 2022 Mar 29, 2022
8-K Current report
Material agreement, New debt
Mar 4, 2022 Feb 28, 2022
8-K/A Amended current report Dec 14, 2021 Dec 13, 2021
8-K Current report
Regulation FD disclosure
Dec 14, 2021 Dec 13, 2021
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Dec 13, 2021 Dec 13, 2021
8-K Current report
Restatement
Nov 18, 2021 Nov 15, 2021
8-K Current report
Other events
May 17, 2021 May 14, 2021
8-K Current report
Other events
Apr 19, 2021 Apr 19, 2021
8-K Current report
Other events
Mar 11, 2021 Mar 4, 2021
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Mar 5, 2021 Mar 1, 2021

Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
BTMD (Nasdaq)
Fiscal year ends
December 31
Headquarters
Irving, TX
SEC filer status
Accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1819253
Former names
Haymaker Acquisition Corp. III (until May 25, 2022)

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.